| Genomic Medicine |
1 |
1 |
| Genetics |
0 |
0.99 |
| Genetic Testing |
0 |
0.71 |
| Gene Editing |
0 |
0.7 |
| Charcot-Marie-Tooth |
0 |
0.41 |
| Muscular Atrophy |
0 |
0.4 |
| Neuropathy |
0 |
0.26 |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
0 |
0.19 |
| CRISPR |
0 |
0.19 |
| Healthcare and Medical Technology |
0 |
0.18 |
| Clinical Research |
0 |
0.17 |
| Spinal Muscular Atrophy |
0 |
0.1 |
| Demyelination |
0 |
0.09 |
| Insurance |
0 |
0.09 |
| Muscle |
0 |
0.09 |
| Nerve |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |